Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors
Clinical trial NCT05156203 · RECRUITING
Trial details
- NCT number
- NCT05156203
- Sponsor
- Taivex Therapeutics Corporation
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-19
- Primary completion
- 2027-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.